← SynDRA
PARBENDAZOLE
SynDRA canonical compound SYN0019050 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | TUBB |
| Mechanism of action | Tubulin inhibitor |
All known targets
Mechanisms of action (all sources)
- microtubule inhibitor
- tubulin polymerization inhibitor
Drug classes
Cross-references
Synonyms
- Parbendazol
- NSC-256420
- SK&F-29044
- TCMDC-131798
- Helmatac
- Methyl (5-butyl-1H-benzo[d]imidazol-2-yl)carbamate
- Worm Guard
- Verminum
- SKF-29044
- Helatac
- PBDZ
- METHYL 5-BUTYL-2-BENZIMIDAZOLECARBAMATE
- Carbamic acid, (5-butyl-1H-benzimidazol-2-yl)-, methyl ester
- methyl N-(6-butyl-1H-benzimidazol-2-yl)carbamate
- Parbendazole free base
- 5-Butyl-2-(carbomethoxyamino)benzimidazole
- N4X8WVX2UG
- 5-Butyl-2-benzimidazolecarbamic acid methyl ester
- NSC 256420
- 14255-87-9 (free base)
- NCGC00016706-01
- CAS-14255-87-9
- Methyl (5-butyl-1H-benzimidazol-2-yl)carbamate
- Methyl 5-butyl-1H-benzo[d]imidazol-2-ylcarbamate
- methyl ~{N}-(5-butyl-1~{H}-benzimidazol-2-yl)carbamate
- Parbendazolum
- N-(6-Butyl-1H-benzimidazol-2-yl)carbamic Acid Methyl Ester
- Parbendazol [INN-Spanish]
- Parbendazolum [INN-Latin]
- EINECS 238-133-3
- UNII-N4X8WVX2UG
- Parbendazole [USAN:INN:BAN]
- 2-Benzimidazolecarbamic acid, 5-butyl-, methyl ester
- (4-Butyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
- N-(Butyl-5, benzimidazolyl)-2, carbamate de methyle [French]
- Methyl 5(6)-butyl-2-benzimidazolecarbamate
- Prestwick0_001110
- Prestwick1_001110
Look up PARBENDAZOLE in the interactive SynDRA portal →